These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38967908)

  • 21. Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.
    Federico Paly V; Kurt M; Zhang L; Butler MO; Michielin O; Amadi A; Hernlund E; Johnson HM; Kotapati S; Moshyk A; Borrill J
    MDM Policy Pract; 2022; 7(1):23814683221089659. PubMed ID: 35356551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health technology assessment of medical devices: a survey of non-European union agencies.
    Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
    Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies.
    Haji Ali Afzali H; Street J; Merlin T; Karnon J
    Int J Technol Assess Health Care; 2021 Jan; 37():e22. PubMed ID: 33455592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-, under- and misuse of pain treatment in Germany.
    Dietl M; Korczak D
    GMS Health Technol Assess; 2011 Apr; 7():Doc03. PubMed ID: 21522485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fitting parametric cure models in R using the packages cuRe and rstpm2.
    Jensen RK; Clements M; Gjærde LK; Jakobsen LH
    Comput Methods Programs Biomed; 2022 Nov; 226():107125. PubMed ID: 36126436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results.
    Marks Y; Hoch JS; Heath A; Pechlivanoglou P
    Pharmacoeconomics; 2024 Jul; 42(7):783-795. PubMed ID: 38607519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making.
    Teerawattananon Y; Painter C; Dabak S; Ottersen T; Gopinathan U; Chola L; Chalkidou K; Culyer AJ
    Cost Eff Resour Alloc; 2021 Sep; 19(1):62. PubMed ID: 34551780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EMERGENCE OF "DRIVERS" FOR THE IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT.
    Castro Jaramillo HE; Moreno-Mattar O; Osorio-Cuevas D
    Int J Technol Assess Health Care; 2016 Jan; 32(4):300-306. PubMed ID: 27691993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Gopinathan U; Ottersen T; Cyr PR; Chalkidou K
    Int J Health Policy Manag; 2021 Mar; 10(4):232-236. PubMed ID: 32772012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.
    Wortley S; Tong A; Lancsar E; Salkeld G; Howard K
    BMC Med Inform Decis Mak; 2015 Jul; 15():52. PubMed ID: 26166149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments.
    Yang WW; Juan YC; Wu GH; Pwu RF
    Drug Saf; 2024 Apr; 47(4):289-299. PubMed ID: 38113017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How accurate are the longer-term projections of overall survival for cancer immunotherapy for standard versus more flexible parametric extrapolation methods?
    Cooper M; Smith S; Williams T; Aguiar-Ibáñez R
    J Med Econ; 2022; 25(1):260-273. PubMed ID: 35060433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.
    Frønsdal KB; Facey K; Klemp M; Norderhaug IN; Mørland B; Røttingen JA
    Int J Technol Assess Health Care; 2010 Jul; 26(3):309-16. PubMed ID: 20584360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National health technology assessment in Turkiye after a decade: are key principles followed?
    Avşar TS; Yıldırım HH
    Int J Technol Assess Health Care; 2023 Jul; 39(1):e52. PubMed ID: 37485616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the quality of health technology assessment reports in a developing country.
    Sabermahani A; Yazdi-Feyzabadi V; Bashzar S
    East Mediterr Health J; 2023 Jul; 29(7):554-561. PubMed ID: 37553743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada.
    Mills M; Kanavos P
    Health Policy; 2022 Nov; 126(11):1130-1143. PubMed ID: 36050193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why ethics should be part of health technology assessment.
    Hofmann BM
    Int J Technol Assess Health Care; 2008; 24(4):423-9. PubMed ID: 18828936
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.